Adicet Bio 10-Q 2019 Q2 Quarterly report

Exhibit 15.1

February 20, 2019

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

We are aware that Aceto Corporation and subsidiaries has incorporated by reference in its Registration Statements on Form S-3 (No. 333-227896 and No. 333-207394) and Form S-8 (No. 333-209693, No. 333-187353, No. 333-174834, No. 333-149586, No. 333-90929, and No. 333-110653) our report dated February 20, 2019, relating to the Company’s unaudited interim consolidated financial statements appearing in its quarterly report on Form 10-Q for the quarter ended September 30, 2018. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern. Pursuant to Regulation C under the Securities Act of 1933, that report is not considered a part of the registration statement prepared or certified by our firm or a report prepared or certified by our firm within the meaning of Sections 7 and 11 of the Act. It should be noted that we have not performed any procedures subsequent to February 20, 2019.

/s/ BDO USA, LLP

Melville, New York